Page results
-
This page provides information about food and drink which may affect your ileostomy output.
-
This information explains brain stem death and the tests used to confirm the diagnosis. It aims to answer frequently asked questions.
-
This page has been written for patients who are having radioactive iodine (131I) ablation and/or radioiodine treatment for thyroid cancer.
-
This page is for parents and carers whose child is having radiotherapy treatment to the pelvis.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the spine (backbone).
-
This page has been written for parents and carers whose child is having total body irradiation (TBI) for leukaemia, lymphoma, or some other rare blood disorder.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the whole brain and spine. This treatment may also be referred to as whole central nervous system (CNS) or cranio-spinal radiotherapy.
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG treatment.
-
This information is for UCLH patients with cancer or a blood condition who are being offered a PICC (peripherally inserted central catheter).
-
This page explains what you can expect after you have been referred to the Lymphoedema Service at University College London Hospitals (UCLH) for a face-to-face appointment.
File results
-
FOI/2022/0432 - Bariatric surgery operations
-
FOI/2022/0433 - A&E attendances with effects of heat, light and sunburn
-
FOI/2022/0437 - IT infrastructure systems used at Trust
-
FOI/2022/0443 - Trust spend on lost, stolen or damaged patient property
-
FOI/2022/0448 - Electronic cloud based job evaluation system
-
FOI/2022/0449 - Use of defibrotide for the treatment of Hepatic Veno-occlusive disease
-
FOI/2022/0451 - Patient information leaflets
-
FOI/2022/0454 - Temporary staff waiting list initiative and overtime spend
-
FOI/2022/0456 - Treatment of renal cell carcinoma
-
FOI/2022/0459 - Interpreters and translation services